Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2019, Article ID 9356728, 12 pages
https://doi.org/10.1155/2019/9356728
Research Article

Immune Mediator Profile in Aqueous Humor Differs in Patients with Primary Acquired Ocular Toxoplasmosis and Recurrent Acute Ocular Toxoplasmosis

1Department of Ophthalmology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Germany
2Institute for Medical Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Germany

Correspondence should be addressed to Claudia Thieme; moc.liamelgoog@2eveaidualc

Received 25 May 2018; Revised 12 September 2018; Accepted 6 December 2018; Published 17 February 2019

Academic Editor: Marcella Reale

Copyright © 2019 Claudia Thieme et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Maenz, D. Schluter, O. Liesenfeld, G. Schares, U. Gross, and U. Pleyer, “Ocular toxoplasmosis past, present and new aspects of an old disease,” Progress in Retinal and Eye Research, vol. 39, pp. 77–106, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Delair, C. Creuzet, J. Dupouy-Camet, and M. P. Roisin, “In vitro effect of TNF-α and IFN-γ in retinal cell infection with Toxoplasma gondii,” Investigative Ophthalmology & Visual Science, vol. 50, no. 4, pp. 1754–1760, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. D. C. Herrmann, P. Maksimov, A. Hotop et al., “Genotyping of samples from German patients with ocular, cerebral and systemic toxoplasmosis reveals a predominance of Toxoplasma gondii type II,” International Journal of Medical Microbiology, vol. 304, no. 7, pp. 911–916, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. L. M. Kortbeek, A. Hofhuis, C. D. Nijhuis, and A. H. Havelaar, “Congenital toxoplasmosis and DALYs in the Netherlands,” Memorias do Instituto Oswaldo Cruz, vol. 104, no. 2, pp. 370–373, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Talabani, T. Mergey, H. Yera et al., “Factors of occurrence of ocular toxoplasmosis. A review,” Parasite, vol. 17, no. 3, pp. 177–182, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. A. de-la-Torre, A. W. Pfaff, M. E. Grigg, O. Villard, E. Candolfi, and J. E. Gomez-Marin, “Ocular cytokinome is linked to clinical characteristics in ocular toxoplasmosis,” Cytokine, vol. 68, no. 1, pp. 23–31, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Goldmann and R. Witmer, “Antibodies in the aqueous humor,” Ophthalmologica, vol. 127, no. 4-5, pp. 323–330, 1954. View at Publisher · View at Google Scholar
  8. U. Pleyer and P. Ruokonen, “Aqueous humor analysis: a diagnostic tool in intraocular inflammation,” Klinische Monatsblätter für Augenheilkunde, vol. 227, no. 12, pp. 953–960, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. G. N. Holland, “Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management,” American Journal of Ophthalmology, vol. 137, no. 1, pp. 1–17, 2004. View at Publisher · View at Google Scholar
  10. D. A. Jabs, R. B. Nussenblatt, J. T. Rosenbaum, and Standardization of Uveitis Nomenclature Working G, “Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop,” American Journal of Ophthalmology, vol. 140, no. 3, pp. 509–516, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. “Graph pad prism 6,” December 2015, http://www.graphpad.com/.
  12. R Core Team, R: a Language and Environment for Statistical Computing and Graphics, R Foundation for Statistical Computing, 2014, http://www.r-project.org/.
  13. M. Ang, D. V. Vasconcelos-Santos, K. Sharma et al., “Diagnosis of ocular tuberculosis,” Ocular Immunology and Inflammation, vol. 26, no. 2, pp. 208–216, 2018. View at Publisher · View at Google Scholar · View at Scopus
  14. L. de Visser, J. H. de Boer, G. T. Rijkers et al., “Cytokines and chemokines involved in acute retinal necrosis,” Investigative Ophthalmology & Visual Science, vol. 58, no. 4, pp. 2139–2151, 2017. View at Publisher · View at Google Scholar · View at Scopus
  15. H. P. A. Hughes, “Oxidative killing of intracellular parasites mediated by macrophages,” Parasitology Today, vol. 4, no. 12, pp. 340–347, 1988. View at Publisher · View at Google Scholar · View at Scopus
  16. L. D. Sibley, L. B. Adams, Y. Fukutomi, and J. L. Krahenbuhl, “Tumor necrosis factor-alpha triggers antitoxoplasmal activity of IFN-gamma primed macrophages,” The Journal of Immunology, vol. 147, pp. 2340–2345, 1991. View at Google Scholar
  17. C. A. Cordeiro, E. L. M. Vieira, V. M. Castro et al., “T cell immunoregulation in active ocular toxoplasmosis,” Immunology Letters, vol. 184, pp. 84–91, 2017. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Suzuki, Q. Sa, M. Gehman, and E. Ochiai, “Interferon-gamma- and perforin-mediated immune responses for resistance against Toxoplasma gondii in the brain,” Expert Reviews in Molecular Medicine, vol. 13, article e31, 2011. View at Publisher · View at Google Scholar
  19. C. S. Meira, V. L. Pereira-Chioccola, J. E. Vidal et al., “Cerebral and ocular toxoplasmosis related with IFN-γ, TNF-α, and IL-10 levels,” Frontiers in Microbiology, vol. 5, p. 492, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Sher, I. P. Oswald, S. Hieny, and R. T. Gazzinelli, “Toxoplasma gondii induces a T-independent IFN-gamma response in natural killer cells that requires both adherent accessory cells and tumor necrosis factor-alpha,” The Journal of Immunology, vol. 150, pp. 3982–3989, 1993. View at Google Scholar
  21. E. Rochet, J. Brunet, M. Sabou et al., “Interleukin-6-driven inflammatory response induces retinal pathology in a model of ocular toxoplasmosis reactivation,” Infection and Immunity, vol. 83, no. 5, pp. 2109–2117, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Jebbari, C. W. Roberts, D. J. Ferguson, H. Bluethmann, and J. Alexander, “A protective role for IL-6 during early infection with toxoplasma gondii,” Parasite Immunology, vol. 20, no. 5, pp. 231–239, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Ohta, S. Yamagami, A. W. Taylor, and J. W. Streilein, “IL-6 antagonizes TGF-β and abolishes immune privilege in eyes with endotoxin-induced uveitis,” Investigative Ophthalmology & Visual Science, vol. 41, no. 9, pp. 2591–2599, 2000. View at Google Scholar
  24. I. Lahmar, A. Abou-Bacar, T. Abdelrahman et al., “Cytokine profiles in toxoplasmic and viral uveitis,” The Journal of Infectious Diseases, vol. 199, no. 8, pp. 1239–1249, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. A. de-la-Torre, A. Sauer, A. W. Pfaff et al., “Severe South American ocular toxoplasmosis is associated with decreased Ifn-γ/Il-17a and increased Il-6/Il-13 intraocular levels,” PLoS Neglected Tropical Diseases, vol. 7, no. 11, article e2541, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Sauer, A. W. Pfaff, O. Villard et al., “Interleukin 17A as an effective target for anti-inflammatory and antiparasitic treatment of toxoplasmic uveitis,” The Journal of Infectious Diseases, vol. 206, no. 8, pp. 1319–1329, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Sauer, O. Villard, C. Creuzot-Garcher et al., “Intraocular levels of interleukin 17A (IL-17A) and IL-10 as respective determinant markers of toxoplasmosis and viral uveitis,” Clinical and Vaccine Immunology, vol. 22, no. 1, pp. 72–78, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Guiton, V. Vasseur, S. Charron et al., “Interleukin 17 receptor signaling is deleterious during Toxoplasma gondii infection in susceptible BL6 mice,” The Journal of Infectious Diseases, vol. 202, no. 3, pp. 427–435, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. I. Dimier-Poisson, F. Aline, M. N. Mevelec, C. Beauvillain, D. Buzoni-Gatel, and D. Bout, “Protective mucosal Th2 immune response against Toxoplasma gondii by murine mesenteric lymph node dendritic cells,” Infection and Immunity, vol. 71, no. 9, pp. 5254–5265, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. R. T. Gazzinelli, M. Wysocka, S. Hieny et al., “In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha,” The Journal of Immunology, vol. 157, pp. 798–805, 1996. View at Google Scholar
  31. P. Licona-Limon, A. Arias-Rojas, and E. Olguin-Martinez, “IL-9 and Th9 in parasite immunity,” Seminars in Immunopathology, vol. 39, no. 1, pp. 29–38, 2017. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Norose, A. Kikumura, A. D. Luster, C. A. Hunter, and T. H. Harris, “CXCL10 is required to maintain T-cell populations and to control parasite replication during chronic ocular toxoplasmosis,” Investigative Ophthalmology & Visual Science, vol. 52, no. 1, pp. 389–398, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. C. F. Denney, L. Eckmann, and S. L. Reed, “Chemokine secretion of human cells in response to Toxoplasma gondii infection,” Infection and Immunity, vol. 67, no. 4, pp. 1547–1552, 1999. View at Google Scholar
  34. J. G. Garweg, J. N. Scherrer, and M. Halberstadt, “Recurrence characteristics in European patients with ocular toxoplasmosis,” British Journal of Ophthalmology, vol. 92, no. 9, pp. 1253–1256, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. G. N. Holland, C. M. Crespi, N. ten Dam-van Loon et al., “Analysis of recurrence patterns associated with toxoplasmic retinochoroiditis,” American Journal of Ophthalmology, vol. 145, no. 6, pp. 1007–1013.e1, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. G. N. Holland, “Ocular toxoplasmosis: the influence of patient age,” Memórias do Instituto Oswaldo Cruz, vol. 104, no. 2, pp. 351–357, 2009. View at Publisher · View at Google Scholar · View at Scopus